Biogen (BIIB) Helped Healthcare Funds Like This One Dominate The Third Quarter
The majority of hedge funds and other top money managers tend to have a long-term focus when they make investments.
Posts Tagged ‘Biogen Idec Inc (BIIB)’
Four Earnings Beats, Four Stocks Making A Morning Move
Four companies have reported their latest quarterly earnings since yesterday’s market close, and all four managed to top estimates, sending their shares up in morning trading...
Biogen Idec Inc (BIIB), Celgene Corporation (CELG), bluebird bio Inc (BLUE): Stanley Druckenmiller Bets on Biotech and Wins
In the last couple of years, biotechnology industry has been a hot topic and investors have been watching closely as the industry gained on average 40% in the last three years...
Gilead Sciences (GILD), AstraZeneca (AZN), Bellicum Pharmaceuticals (BLCM): Redmile Group’s Top New Picks
Jeremy Green’s Redmile Group entered several new positions last quarter, as revealed by the 13F Form it filed with the U.S. Securities and Exchange Commission in February.
Gilead Sciences, Inc., Amgen, Inc., Biogen Idec Inc Among Billionaires’ 5 Hottest Biotech Picks
With the high volatility prevalent in the biotechnology sector, investors have a hard time picking the right stocks to invest in.
Billionaire Stanley Druckenmiller’s Top 5 Picks Include Biogen Idec Inc (BIIB), Target Corporation (TGT), Home Depot Inc (HD)
Billionaire Stanley Druckenmiller’s Duquesne Capital revealed its top 5 picks going into 2015 last week. According to the 13F Form filed with the U.S.
Biogen Idec Inc (BIIB) Making Headway In Key New Drug: Meg Tirrell
Biogen Idec Inc (NASDAQ:BIIB) might be a step closer in finding a cure for Alzheimer's, as the company revealed some promising progress on that front today, which also saw the...
Biogen Idec Inc (BIIB) and Gilead Sciences, Inc. (GILD) Two of the Three Hottest Biotech Stocks You Must Own
Biogen Idec Inc (NASDAQ:BIIB) and Gilead Sciences, Inc.
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen Idec Inc (BIIB): Orbimed Advisors Top Stocks in Q2
Orbimed Advisors, led by Samuel Isaly, recently published its 13F filing with the U.S. Securities and Exchange Commission.
Biotech Top Gainers: Biogen Idec Inc. (BIIB) and Intuitive Surgical, Inc. (ISRG)
Corporate earnings season is already in full swing presenting an opportunity to watch the headline revenues and earnings per share of stocks in the market affected by various ...
Biogen Idec Inc (BIIB) & TESARO Inc (TSRO): Top Biotech Stocks from Robyn Karnauskas Of Deutsche Bank
In the back drop of the biotech S&P ETF impacted by the S&P shedding market valuation by close to 7 % this week, Robyn Karnauskas who heads Deutsche Bank’s biotechnology vertical...
Stuart Weisbrod’s Iguana Healthcare Management Is Fond of These Stocks
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010.
Rock Springs Capital Management’s Top 5 Largest Stock Picks
Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent 14 years working at T.
Four Reasons to Buy This Biotechnology Stock
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best performing stocks in the ...
SPDR S&P Homebuilders (ETF) (XHB), Abercrombie & Fitch Co. (ANF), Novartis AG (ADR) (NVS): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013
The Chinese calendar says 2013 is the year of the snake, but the market says it's the year of biotech.
Biogen Idec Inc (BIIB), ISIS Pharmaceuticals, Inc. (ISIS), Alnylam Pharmaceuticals, Inc. (ALNY): A Ringing Endorsement of a Technology Years in the Making
For the latest deal, Biogen Idec Inc (NASDAQ:BIIB) is giving Isis $100 million up front, and ISIS Pharmaceuticals, Inc.
Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains
I know it's like comparing apples and oranges, but humor me for a moment.
Why XenoPort, Inc. (XNPT) Shares Zoomed Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)
Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years.
Biogen Idec Inc (BIIB): Why ISIS Pharmaceuticals, Inc. (ISIS) Shares Leapt Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Regeneron Pharmaceuticals Inc (REGN), Time Warner Cable Inc (TWC), Biogen Idec Inc. (BIIB): Tuesday’s Best Stocks
Based on today's economic data, you would certainly have expected a more robust rally than what the broad-based S&P 500 (INDEXSP:.INX) ended up gaining, but beggars can't be...
Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?
As an investor in the health care sector, it can sometimes feel like everything -- and everyone -- is out to get you.
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
If you were to ask many investors, hedge funds are viewed as delayed, outdated investment vehicles of an era lost to time.
Carl Icahn News: Leveraged Buyout, Nuance Communications Inc. (NUAN)’s Split Role & Apple Inc. (AAPL)
While Carl Icahn’s team overseeing his investment in Nuance Communications Inc.
Do Hedge Funds and Insiders Love Alexion Pharmaceuticals, Inc. (ALXN)?
In the 21st century investor’s toolkit, there are dozens of indicators investors can use to analyze Mr. Market.
Hedge Funds Are Buying Amgen, Inc. (AMGN)
To the average investor, there are tons of metrics shareholders can use to analyze stocks. Some of the most innovative are hedge fund and insider trading activity.
This Biogen Idec Inc. (BIIB) Data is Screaming ‘Buy, Buy, Buy’
To many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Is Celgene Corporation (CELG) Going to Burn You?
To many traders, hedge funds are perceived as overrated, outdated investment tools of a forgotten age.
Biogen Idec Inc. (BIIB), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Novartis AG (ADR) (NVS): Companies Leading the Fight Against Multiple Sclerosis
It's a disease that doesn't often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are focusing their efforts on to make a quality...
Baxter International Inc. (BAX), Halozyme Therapeutics, Inc. (HALO): This Healthcare Company Is Poised for Growth
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7.38% gain YTD as of Aug 2, ...
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is Tackling Multiple Sclerosis Head On
Currently existing immunomodulatory drugs that treat Multiple Sclerosis only work to treat relapse or attacks, manage symptoms, or modify the course of the disease.
Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Examining an Acquisition That Benefits This Global Healthcare Supplier
Recently, Elan Corporation, plc (ADR) (NYSE:ELN) ended the fight against bids from Royalty Pharma.
Biogen Idec Inc (BIIB), Pfizer Inc. (PFE): Out With the Old, In With the New in Treating MS
Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)'s recent earnings report is a key confirmation of a shifting market in the treatment of multiple sclerosis...
Pharmacyclics, Inc. (PCYC) Set to Glide Higher
Pharmacyclics, Inc. (NASDAQ:PCYC) has been a good company to invest in, especially if you had bought shares back in 2009 when it traded around $1 per share.
Things You Need to Know From Questcor Pharmaceuticals Inc (QCOR)’s Killer Q2 Earnings
Three months ago after Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced its first-quarter financial results, I asked if those results were as bad as they looked.
Elan Corporation, plc (ADR) (ELN), Perrigo Company (PRGO): Strange Biotech Bedfellows
When I interviewed Alkermes Plc (NASDAQ:ALKS)' CEO Richard Pops last year, he described the relocation of the company's headquarters to Ireland where taxes are lower after buying...
Monster Beverage Corp (MNST), Biogen Idec Inc (BIIB): Today’s Worst Stocks
Investors weren't blown away with today's data, which is understandable since there wasn't anything too meaningful released.
Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG): Biotech Favorites With Noteworthy Drug Data
Three of the biggest names in biotechnology have reported earnings, and their quarters involved very important drug-related information for investors.
Questcor Pharmaceuticals Inc (QCOR), Biogen Idec Inc (BIIB): A Biotech Betting Everything on a Single Drug
Despite some negative news, mainly related to reimbursement issues and excess stock booking, Questcor Pharmaceuticals Inc (NASDAQ:QCOR) recently gained solid momentum due to a...
Amgen, Inc. (AMGN), Celgene Corporation (CELG): Is Big Biotech Still Growing?
The first half of 2013 has seen remarkable growth in the biotech sector, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) up >40% YTD. The industry continues to...
Baxter International Inc. (BAX), Medtronic, Inc. (MDT): Should You Buy These 2 Medical Device Stocks?
Medical device stocks are an excellent place to be if you are still wary of the macro-economy.
What Does Celgene Corporation (CELG)’s Failed Trial Mean for Investors?
Early this morning, Celgene Corporation (NASDAQ:CELG) announced that it was discontinuing the phase 3 ORIGIN Trial evaluating Revlimid (lenalidomide) in B-Cell chronic lymphomatic...
Biogen Idec Inc. (BIIB), Celgene Corporation (CELG), Gilead Sciences, Inc. (GILD): 3 of Biotech’s Best
It’s been a healthy year-to-date for the biotech sector, with the space logging huge gains above and beyond those of the broad based market.
Amgen, Inc. (AMGN), Celgene Corporation (CELG), Biogen Idec Inc. (BIIB): Watch Out for These 3 Biotech Companies
This year, the North American players in the biotechnology industry are expected to spend $15 billion.
Is Zoetis Inc (ZTS) Worth the Premium?
After all of the hype and hoopla over Pfizer Inc.
What’s Next for Elan Corporation, plc (ADR) (ELN)?
Elan Corporation, plc (ADR) (NYSE:ELN)'s board unanimously rebuffed a $6.7 billion takeover offer from Royalty Pharma in early June and hired Citigroup Inc.
Valeant Pharmaceuticals Intl Inc (VRX), Hospira, Inc. (HSP), Elan Corporation, plc (ADR) (ELN): 3 Pharma Companies to Buy for the Long Run
According to IMS health report, the global pharmaceutical industry is expected to grow at a CAGR of 4.5% in the next five years to reach $1.20 trillion in 2017, from $963 billion...
